非小细胞肺癌术后辅助化疗研究进展
비소세포폐암술후보조화료연구진전
Advance of Postoperative Adjuvant Therapy in Non-small Cell Lung Cancer
  • 万方数据
    中国肺癌杂志 중국폐암잡지
    CHINESE JOURNAL OF LUNG CANCER
    2014年 6期 501-505 ,共5页

    韩娜%卢红阳

    한나%로홍양

    肺肿瘤%辅助治疗%化学治疗 肺腫瘤%輔助治療%化學治療
    폐종류%보조치료%화학치료
    Lung neoplasms%Adjuvant therapy%Chemotherapy
    肺癌可分为非小细胞肺癌（non-small cell lung cancer, NSCLC）和小细胞肺癌，其发病率和死亡率均高居恶性肿瘤首位。本文主要就NSCLC术后辅助化疗的地位确立、辅助化疗的合适人群和化疗方案选择以及相关生物标志物研究进展作一综述。
    폐암가분위비소세포폐암（non-small cell lung cancer, NSCLC）화소세포폐암，기발병솔화사망솔균고거악성종류수위。본문주요취NSCLC술후보조화료적지위학립、보조화료적합괄인군화화료방안선택이급상관생물표지물연구진전작일종술。
    Lung cancer including non-small cell lung cancer (NSCLC) and SCLC is the most commonly diagnosed cancer and leading cause of cancer-related death worldwide. hTis review focuses on progress of the effect, indications, regimens and the related biological markers of postoperative adjuvant chemotherapy in NSCLC.
    원문보기 원문다운로드 사이트로이동
저자의 최근 논문